Chengyun Liu
About
Chengyun Liu has authored 35 papers that have received a total of 700 indexed citations.
This includes 10 papers in Surgery, 10 papers in Epidemiology and 10 papers in Endocrinology, Diabetes and Metabolism. The topics of these papers are Diabetes, Cardiovascular Risks, and Lipoproteins (8 papers), Liver Disease Diagnosis and Treatment (6 papers) and COVID-19 Clinical Research Studies (6 papers). Chengyun Liu is often cited by papers focused on Diabetes, Cardiovascular Risks, and Lipoproteins (8 papers), Liver Disease Diagnosis and Treatment (6 papers) and COVID-19 Clinical Research Studies (6 papers) and collaborates with scholars based in China, Hong Kong and United States. Chengyun Liu's co-authors include Peiyuan Zuo, Xiaofang Zhao, Xinglin Chen, Songpu Xie and Kun Wang and has published in prestigious journals such as PLoS ONE, Clinical Infectious Diseases and Archives of Biochemistry and Biophysics.
In The Last Decade
side by side view
Countries citing papers authored by Chengyun Liu
Since SpecializationCitations
Explore authors with similar magnitude of impact
Breakdown of academic impact, for papers by Yoshihiro Mano Breakdown of academic impact, for papers by Yinbo Niu Breakdown of academic impact, for papers by Stefan Salzmann Breakdown of academic impact, for papers by Andrea Taylor Breakdown of academic impact, for papers by Younès Filali-Zegzouti Breakdown of academic impact, for papers by John G. Endriz Breakdown of academic impact, for papers by J.-M. Soler Breakdown of academic impact, for papers by Long Chang